The official blog of the Lung Institute.

Interstitial Lung Disease Symptoms and Ways to Manage Them

Interstitial Lung Disease Symptoms and Ways to Manage Them

Interstitial lung disease (ILD) is a general category that includes various lung conditions. These pulmonary disorders affect the absorption of oxygen into the lungs and make breathing difficult. While there are many forms of interstitial lung disease, there are steps you can take to manage your interstitial lung disease symptoms.

What is interstitial lung disease?

Interstitial lung diseases all affect the interstitium, which is part of the lungs’ anatomic structure. The interstitium is a lace-like network of tissues that flows throughout both lungs and provides support to the tiny air sacs or alveoli. Tiny blood vessels travel through the interstitium, allowing gas to exchange between the blood and the air in the lungs. Normally, the interstitium is so thin that it can’t be seen on a chest x-ray or CT scan. Interstitial lung diseases cause the interstitium to thicken, which can occur because of scarring, extra fluid or inflammation.

Typically, the scarring associated with interstitial lung disease causes progressive lung stiffness and eventually affects your ability to breathe. People with interstitial lung disease often have difficulty getting enough oxygen into their bloodstream.

What causes interstitial lung disease?

Because interstitial lung disease can be caused by autoimmune diseases, exposure to organic and inorganic agents in the home or workplace, certain medications and some type of radiation, it can be challenging for doctors to determine a specific cause of interstitial lung disease. In some cases, the cause is unknown and is labeled as idiopathic interstitial pneumonia.

Medical conditions associated with lung damage and inflammation include mixed-connective tissue disease, rheumatoid arthritis (RA), scleroderma, Sjogren’s syndrome and lupus. Medications that can potentially damage your lungs and cause ILD include chemotherapy drugs, certain heart medications and some types of antibiotics. Long-term exposure to organic and inorganic materials can also damage your lungs. These materials include asbestos fibers, bird protein, coal dust, grain dust, mold, cigarette smoke and silica dust.

What are interstitial lung disease symptoms?

The type, severity and progression of interstitial lung disease symptoms varies from person to person. However, there are some common and shared interstitial lung disease symptoms, such as shortness of breath and a dry cough.

Interstitial Lung Disease Symptoms and Ways to Manage Them

Other interstitial lung disease symptoms include:

  • Weight loss
  • Joint pain
  • Fatigue
  • Cyanosis
  • Abnormal enlargement of the fingernail base
  • Acute pneumonia

Ways to manage interstitial lung disease symptoms

While interstitial lung disease is a progressive condition without a cure, meaning it will worsen gradually over time, there are things you can do to manage your symptoms. Depending on your symptoms and type of interstitial lung disease, your doctor may recommend a variety of treatment options.

For example, certain antibiotics may be prescribed if you experience acute pneumonia. Certain forms of interstitial lung disease have ongoing inflammation causing damage in the lungs, so corticosteroids may be prescribed to reduce inflammation. Sometimes medications that suppress the immune system or even a lung transplant could be recommended by your doctor. Because interstitial lung disease makes breathing and getting enough oxygen difficult, your doctor may recommend oxygen therapy to help you improve your blood oxygen level.

Many people have found alternative therapies beneficial in helping them breathe easier, including from stem cell therapy. In fact, after treatment, many patients reported coming off or reducing their oxygen therapy use and were able to perform their daily activities again with more ease. They saw improvements to their interstitial lung disease symptoms. If you or a loved one has interstitial lung disease, pulmonary fibrosis or another chronic lung disease, contact us at (800) 729-3065 to learn more about your treatment options.

Your Comment

Your email address will not be published.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.